Select Publications
By Dr Yue Huang
Journal articles
2017, 'Genetic features of MAPT, GRN, C9orf72 and CHCHD10 gene mutations in Chinese patients with frontotemporal dementia', Current Alzheimer Research, 14, pp. 1102 - 1108, http://dx.doi.org/10.2174/1567205014666170426105713
,2017, 'How does white matter microstructure differ between the vascular and amnestic mild cognitive impairment?', Oncotarget, 8, pp. 42 - 50, http://dx.doi.org/10.18632/oncotarget.13960
,2017, 'Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia', Journal of Alzheimer's Disease, 58, pp. 163 - 170, http://dx.doi.org/10.3233/JAD-161272
,2017, 'SS31 Ameliorates age-related activation of NF-κB signaling in senile mice model, SAMP8', Oncotarget, 8, pp. 1983 - 1992, http://dx.doi.org/10.18632/oncotarget.14077
,2017, 'Book Review: Remark the Book of Landmark Papers in Neurology.', Curr Alzheimer Res, 14, pp. 1348 - 1349, http://dx.doi.org/10.2174/156720501412171030154955
,2016, '中国人脑组织库标准化操作方案 (Standardised Operation Procedure for Human Brain Tissue Banking in China)', Acta Anatomica Sinica
,2016, 'ROCK1 is associated with Alzheimer’s disease-specific plaques, as well as enhances autophagosome formation but not autophagic Aβ clearance', Frontiers in Cellular Neuroscience, 10, http://dx.doi.org/10.3389/fncel.2016.00253
,2016, 'MicroRNA-146a represses LRP2 translation and leads to cell apoptosis in Alzheimer's disease', FEBS Letters, pp. 2190 - 2200, http://dx.doi.org/10.1002/1873-3468.12229
,2016, 'MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease', Scientific Reports, 6, http://dx.doi.org/10.1038/srep26697
,2016, 'Quantitative protein profiling of hippocampus during human aging', Neurobiology of Aging, 39, pp. 46 - 56, http://dx.doi.org/10.1016/j.neurobiolaging.2015.11.029
,2016, 'Translational Alzheimer’s disease research', Current Alzheimer Research, 13, pp. 214, http://dx.doi.org/10.2174/156720501303160217102238
,2016, 'Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease', Parkinsonism and Related Disorders, 24, pp. 89 - 94, http://dx.doi.org/10.1016/j.parkreldis.2015.12.018
,2016, 'Editorial: Translational Alzheimer's Disease Research.', Curr Alzheimer Res, 13, pp. 214 - 214, http://dx.doi.org/10.2174/156720501303160217102238
,2015, 'Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)', Neurobiology of Disease, 82, pp. 445 - 454, http://dx.doi.org/10.1016/j.nbd.2015.07.011
,2015, 'SNCA gene, but not MAPT, influences onset age of Parkinson's disease in Chinese and Australians', BioMed Research International, 2015, pp. 135674, http://dx.doi.org/10.1155/2015/135674
,2014, 'Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis', Frontiers in Molecular Neuroscience, 7, http://dx.doi.org/10.3389/fnmol.2014.00057
,2014, 'Genetics of hereditary neurological disorders in children', Translational Pediatrics, 3, pp. 109 - 119, http://dx.doi.org/10.3978/j.issn.2224-4336.2014.03.04
,2014, 'Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment', Dementia and Geriatric Cognitive Disorders, 37, pp. 223 - 231, http://dx.doi.org/10.1159/000353541
,2014, 'DNA methylation of the MAPT gene in Parkinson's disease cohorts and modulation by vitamin E In Vitro', Movement Disorders, 29, pp. 1606 - 1614, http://dx.doi.org/10.1002/mds.25784
,2013, 'DNA extraction from fresh-frozen and formalin-fixed, paraffinembedded human brain tissue', Neuroscience Bulletin, 29, pp. 649 - 654, http://dx.doi.org/10.1007/s12264-013-1379-y
,2013, 'Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3', CNS Neuroscience and Therapeutics, 19, pp. 688 - 694, http://dx.doi.org/10.1111/cns.12124
,2013, 'Erratum: Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese han population (American Journal of Alzheimer's Disease and Other Dementias (2011) 26:8 (627-630) DOI:10.1177/1533317511432735)', American Journal of Alzheimer's Disease and other Dementias, 28, pp. 715, http://dx.doi.org/10.1177/1533317513502260
,2013, 'Can we clinically diagnose dementia with Lewy bodies yet?', , pp. 1 - 9, http://dx.doi.org/10.1186/2047-9158-2-4
,2013, 'Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease', Journal of Clinical Neuroscience, 20, pp. 1089 - 1094, http://dx.doi.org/10.1016/j.jocn.2012.09.025
,2013, 'LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models', Journal of Molecular Medicine - Jmm, 91, pp. 513 - 522, http://dx.doi.org/10.1007/s00109-012-0984-y
,2012, 'Metabolomics: A novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease', Neuroscience Bulletin, 28, pp. 641 - 648, http://dx.doi.org/10.1007/s12264-012-1272-0
,2012, 'Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation', Translational Neurodegeneration, 1, http://dx.doi.org/10.1186/2047-9158-1-2
,2012, 'High-Sensitivity C-Reactive Protein is a Strong Risk Factor for Death after Acute Ischemic Stroke among Chinese', CNS NEUROSCIENCE & THERAPEUTICS, 18, pp. 261 - 266, http://dx.doi.org/10.1111/j.1755-5949.2012.00296.x
,2012, 'Aspects of innate immunity and Parkinson's disease', Frontiers in Pharmacology, 3, pp. Art. No. 33, http://dx.doi.org/10.3389/fphar.2012.00033
,2012, 'History, present and progress of frontotemporal dementia in China: A systematic review', International Journal of Alzheimer's Disease, 2012, pp. 1 - 6, http://dx.doi.org/10.1155/2012/587215
,2012, 'The potential role of microRNA-146 in Alzheimer's disease: Biomarker or therapeutic target?', Journal of Medical Hypotheses, 78, pp. 398 - 401, http://dx.doi.org/10.1016/j.mehy.2011.11.019
,2011, 'Association study of Clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population', American Journal of Alzheimers Disease and Other Dementias, 26, pp. 627 - 630, http://dx.doi.org/10.1177/1533317511432735
,2011, 'Changes in the solubility and phosphorylation of alpha-synuclein over the course of Parkinson's disease', ACTA Neuropathologica, 121, pp. 695 - 704, http://dx.doi.org/10.1007/s00401-011-0815-1
,2011, 'Clincial correlates of similar pathologies in Parkinsonian syndromes', Movement Disorders, 26, pp. 499 - 506, http://dx.doi.org/10.1002/mds.23336
,2011, 'Clinical phenotypes in autopsy-confirmed pick disease', Neurology, 76, pp. 253 - 259, http://dx.doi.org/10.1212/WNL.0b013e318207b1ce
,2011, 'Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease', Current Alzheimer Research, 8, pp. 765 - 770, http://dx.doi.org/10.2174/156720511797633232
,2011, 'Interaction between a-synuclein and tau genotypes and the progression of Parkinson's disease', Journal of Parkinson's Disease, 1, pp. 271 - 276, http://dx.doi.org/10.3233/JPD-2011-11027
,2011, 'Utility and limitations of Addenbrooke's cognitive examination-revised for detecting mild cognitive impairment in Parkinson's disease', Dementia and Geriatric Cognitive Disorders, 31, pp. 349 - 357, http://dx.doi.org/10.1159/000328165
,2010, '11. Regionally specific diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease', Journal of Clinical Neuroscience, 17, pp. 1613 - 1613, http://dx.doi.org/10.1016/j.jocn.2010.07.012
,2010, '78. Genetic influences of sigma-1 receptor and apolipoprotein E on the severity of Alzheimer’s disease', Journal of Clinical Neuroscience, 17, pp. 1633 - 1633, http://dx.doi.org/10.1016/j.jocn.2010.07.079
,2010, 'Advances in Alzheimer's disease genomics research', Chinese journal of Contemporary Neurology and Neorosurgery, 10, pp. 171 - 176
,2010, 'Immunohistochemical evidence for macroautophagy in neurons and endothelial cells in Alzheimer's disease', Neuropathology and Applied Neurobiology, 36, pp. 312 - 319
,2008, '410: Autosomal dominant late-onset Parkinson’s disease due to a novel A1442P mutation in the LRRK2 gene', Journal of Clinical Neuroscience, 15, pp. 344 - 345, http://dx.doi.org/10.1016/j.jocn.2007.07.023
,2008, 'Clinical and imaging features of a Chinese-speaking man with semantic dementia', Journal of Neurology, 255, pp. 297 - 298, http://dx.doi.org/10.1007/s00415-008-0694-0
,2008, 'LRRK2 and parkin immuoreactivity in multiple system atrophy inclusions', ACTA Neuropathologica, 116, pp. 639 - 646
,2007, '1.210 P25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy', Parkinsonism & Related Disorders, 13, pp. S63 - S63, http://dx.doi.org/10.1016/s1353-8020(08)70483-8
,2007, '307: Prevalence of LRRK2 mutations in Australians with Parkinson’s Disease', Journal of Clinical Neuroscience, 14, pp. 1009 - 1010, http://dx.doi.org/10.1016/j.jocn.2007.02.013
,2007, 'p25alpha relocalizes in oligodedroglia from myelin to cytoplasmic inclusions in multiple system atrophy', American Journal of Pathology, 171, pp. 1291 - 1303
,2007, 'Parkin co-regulated gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of parkinsonian diseases', Neurobiology of Disease, 27, pp. 238 - 247
,2007, 'Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson`s disease', Movement Disorders, 27, pp. 982 - 989
,